BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 927 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $381,000 | +0.5% | 4,656 | 0.0% | 0.20% | -2.9% |
Q1 2019 | $379,000 | +57.9% | 4,656 | +1.0% | 0.21% | +40.1% |
Q2 2018 | $240,000 | -20.0% | 4,610 | 0.0% | 0.15% | -20.5% |
Q1 2018 | $300,000 | +0.7% | 4,610 | 0.0% | 0.18% | +6.9% |
Q4 2017 | $298,000 | -16.1% | 4,610 | -18.6% | 0.17% | -19.5% |
Q3 2017 | $355,000 | -30.3% | 5,664 | -32.6% | 0.22% | -28.6% |
Q2 2017 | $509,000 | +81.1% | 8,408 | +42.4% | 0.30% | +83.5% |
Q1 2017 | $281,000 | +7.3% | 5,906 | 0.0% | 0.16% | +8.6% |
Q4 2016 | $262,000 | -6.8% | 5,906 | 0.0% | 0.15% | +77.6% |
Q3 2016 | $281,000 | +5.2% | 5,906 | 0.0% | 0.08% | -46.5% |
Q2 2016 | $267,000 | +16.1% | 5,906 | -1.6% | 0.16% | +4.6% |
Q1 2016 | $230,000 | 0.0% | 6,004 | 0.0% | 0.15% | -9.0% |
Q4 2015 | $230,000 | -42.9% | 6,004 | +4.2% | 0.17% | -45.6% |
Q2 2015 | $403,000 | +1.5% | 5,762 | 0.0% | 0.31% | +2.3% |
Q1 2015 | $397,000 | -2.7% | 5,762 | +3.6% | 0.30% | -10.4% |
Q4 2014 | $408,000 | – | 5,562 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |